Literature DB >> 12937174

Structural basis for substrate specificity of Escherichia coli purine nucleoside phosphorylase.

Eric M Bennett1, Chenglong Li, Paula W Allan, William B Parker, Steven E Ealick.   

Abstract

Purine nucleoside phosphorylase catalyzes reversible phosphorolysis of purine nucleosides and 2'-deoxypurine nucleosides to the free base and ribose (or 2'-deoxyribose) 1-phosphate. Whereas the human enzyme is specific for 6-oxopurine ribonucleosides, the Escherichia coli enzyme accepts additional substrates including 6-oxopurine ribonucleosides, 6-aminopurine ribonucleosides, and to a lesser extent purine arabinosides. These differences have been exploited in a potential suicide gene therapy treatment for solid tumors. In an effort to optimize this suicide gene therapy approach, we have determined the three-dimensional structure of the E. coli enzyme in complex with 10 nucleoside analogs and correlated the structures with kinetic measurements and computer modeling. These studies explain the preference of the enzyme for ribose sugars, show increased flexibility for active site residues Asp204 and Arg24, and suggest that interactions involving the 1- and 6-positions of the purine and the 4'- and 5'-positions of the ribose provide the best opportunities to increase prodrug specificity and enzyme efficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937174     DOI: 10.1074/jbc.M304622200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues.

Authors:  Agnes Rinaldo-Matthis; Corin Wing; Mahmoud Ghanem; Hua Deng; Peng Wu; Arti Gupta; Peter C Tyler; Gary B Evans; Richard H Furneaux; Steven C Almo; Ching C Wang; Vern L Schramm
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 2.  Intratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.

Authors:  Turang E Behbahani; Eben L Rosenthal; William B Parker; Eric J Sorscher
Journal:  Head Neck       Date:  2019-01-11       Impact factor: 3.147

3.  Crowding, molecular volume and plasticity: an assessment involving crystallography, NMR and simulations.

Authors:  M Selvaraj; Rais Ahmad; Umesh Varshney; M Vijayan
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

4.  Design and directed evolution of a dideoxy purine nucleoside phosphorylase.

Authors:  David P Nannemann; Kristian W Kaufmann; Jens Meiler; Brian O Bachmann
Journal:  Protein Eng Des Sel       Date:  2010-06-04       Impact factor: 1.650

5.  Inhibition of Salmonella enterica biofilm formation using small-molecule adenosine mimetics.

Authors:  Jacob A Koopman; Joanna M Marshall; Aditi Bhatiya; Tadesse Eguale; Jesse J Kwiek; John S Gunn
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

6.  Structural basis of the substrate specificity of Bacillus cereus adenosine phosphorylase.

Authors:  Paola Dessanti; Yang Zhang; Simone Allegrini; Maria Grazia Tozzi; Francesco Sgarrella; Steven E Ealick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-02-14

7.  The crystal structure of Streptococcus pyogenes uridine phosphorylase reveals a distinct subfamily of nucleoside phosphorylases.

Authors:  Timothy H Tran; S Christoffersen; Paula W Allan; William B Parker; Jure Piskur; I Serra; M Terreni; Steven E Ealick
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

8.  Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Authors:  William B Parker; Eric J Sorscher
Journal:  Curr Pharm Des       Date:  2017-11-08       Impact factor: 3.116

9.  Purine nucleoside phosphorylase from Pseudoalteromonas sp. Bsi590: molecular cloning, gene expression and characterization of the recombinant protein.

Authors:  Xiaohui Li; Xinyin Jiang; Huirong Li; Daming Ren
Journal:  Extremophiles       Date:  2008-02-26       Impact factor: 2.395

10.  Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine.

Authors:  Sepideh Afshar; Michael R Sawaya; Sherie L Morrison
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.